2020-08328. Importer of Controlled Substances Application: VHG Labs DBA LGC Standards  

  • Start Preamble

    ACTION:

    Notice of application.

    DATES:

    Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 20, 2020. Such persons may also file a written request for a hearing on the application on or before May 20, 2020.

    ADDRESSES:

    Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 1301.34(a), this is notice that on March 12, 2020, VHG Labs DBA LGC Standards, 3 Perimeter Road, Manchester, New Hampshire 03103, applied to be registered as an importer of the following basic class(es) of controlled substances:

    Controlled substanceDrug codeSchedule
    Cathinone1235I
    Methcathinone1237I
    Naphyrone1258I
    N-Ethylamphetamine1475I
    JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole)6250I
    SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole)7008I
    APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide7048I
    JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole)7081I
    SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole7104I
    JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole)7118I
    JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole)7122I
    UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone7144I
    JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole)7203I
    Ibogaine7260I
    Lysergic acid diethylamide7315I
    Marihuana Extract7350I
    Marihuana7360I
    Tetrahydrocannabinols7370I
    Mescaline7381I
    JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole)7398I
    3,4-Methylenedioxymethamphetamine7405I
    5-Methoxy-N-N-dimethyltryptamine7431I
    Psilocyn7438I
    4-Methyl-alphapyrrolidinopropiophenone (4-MePPP)7498I
    MDPV (3,4-Methylenedioxypyrovalerone)7535I
    Methylone (3,4-Methylenedioxy-N-methylcathinone)7540I
    Butylone7541I
    Pentylone7542I
    Codeine-N-oxide9053I
    Start Printed Page 21889
    Desomorphine9055I
    Dihydromorphine9145I
    Heroin9200I
    Morphine-N-oxide9307I
    Normorphine9313I
    Tilidine9750I
    Alpha-methylfentanyl9814I
    Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)9821I
    Methamphetamine1105II
    Phenmetrazine1631II
    Methylphenidate1724II
    Amobarbital2125II
    Pentobarbital2270II
    Secobarbital2315II
    Glutethimide2550II
    Phencyclidine7471II
    Phenylacetone8501II
    Codeine9050II
    Dihydrocodeine9120II
    Diphenoxylate9170II
    Ecgonine9180II
    Ethylmorphine9190II
    Hydrocodone9193II
    Levorphanol9220II
    Meperidine9230II
    Meperidine intermediate-B9233II
    Meperidine intermediate-C9234II
    Dextropropoxyphene, bulk (non-dosage forms)9273II
    14-Hydroxmorphone9665II
    Noroxymorphone9668II
    Sufentanil9740II
    Fentanyl9801II

    The company plans to import the listed controlled substances for sale to research facilities for drug testing and analysis. In reference to drug codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols) the company plans to import a synthetic cannabidiol and a synthetic tetrahydrocannabinols. No other activities for these drug codes are authorized for this registration.

    Start Signature

    William T. McDermott,

    Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2020-08328 Filed 4-17-20; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
04/20/2020
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2020-08328
Dates:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 20, 2020. Such persons may also file a written request for a hearing on the application on or before May 20, 2020.
Pages:
21888-21889 (2 pages)
Docket Numbers:
Docket No. DEA-624
PDF File:
2020-08328.pdf